Between 2011 and 2013, concurrent chemoradiotherapy with IMRT was performed for 11 advanced oropharyngeal cancer patients and median follow-up was 11 months. The local-regional failure was not observed. Acute incidence of grade 2 xerostomia was 7 patients (64%). After 6 and 12 months, grade 2 xerostomia was 11% and 0%, respectively. Further follow-up was required to evaluate local control and the late adverse events after IMRT.
|Number of pages||8|
|Journal||Japanese Journal of Clinical Radiology|
|Publication status||Published - 2014 Oct 1|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging